SELPLG and HIV infectious disease: We are of the opinion that, during HIV infection, PSGL-1 (which has also been observed to be an immune checkpoint inhibitor for T-cells [82,83]) may be a reliable potential biomarker of cellular exhaustion during HIV infection (particularly in ART-treated individuals).